Publication:


abstract

Context: Studies in adults have reported Associations of low circulating total 25-hydroxyvitamin D with increased cardiovascular disease and risk factors. Evidence of associations in children, however, is limited, and it is unknown whether associations with risk factors differ for each 25-hydroxyvitamin D analog [25-hydroxyvitamin D(2) (25[OH]D(2)) and 25-hydroxyvitamin D(2) (25[OH]D(3))]. Objective: The objective of the study was to compare associations of 25(OH)D(2) and 25(OH)D(3) with cardiovascular risk factors in children. Design/Setting: The design of the study was a cross-sectional study of 4274 children (mean age 9.9 yr) from the avon longitudinal Study of parents and Children. Main Outcomes: The main outcomes included blood pressure, lipids [triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C)], apolipoproteins (Apo-A1 and Apo-B), adiponectin, leptin, C-reactive protein, and IL-6. Results: In confounder-adjusted models, 25(OH)D(2) was inversely associated with Apo-A1 (change per doubling of exposure: -0.74mg/dl; 95% confidence interval -0.14, -0.04) and triglycerides (relative percentage change per doubling of exposure: -1.64%; -3.27, 0.01) and positively associated with C-reactive protein (8.42%; 3.40, 13.58) and IL-6 (5.75%; 1.83, 9.25). 25(OH)D(3) was positively associated with HDL-C (0.04 mmol/liter; 0.02, 0.06), Apo-A1 (1.96 mg/dl; 0.65, 3.24), and adiponectin (0.47 μg/ml; 0.15, 0.79). There was statistical evidence that associations of 25(OH)D(2) and 25(OH)D(3) with HDL-C, Apo-A1, and IL-6 differed from each other (all P values for differences ≤0.02). Conclusions: Higher circulating 25(OH)D(3) was associated with cardioprotective levels of HDL-C, Apo-A1, and adiponectin in children. Associations of 25(OH)D(2) with cardiovascular risk factors were in mixed directions. It is necessary to see whether these associations are replicated in large prospective studies.

Related Articles
Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.
BMJ. 2010
Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.
Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, Fraser A, Cherry L, Watt P, Ness AR, Davey Smith G, et al. BMJ. 2010 Nov 25; 341:c6224. Epub 2010 Nov 25.
25-Hydroxyvitamin-D(3) levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study.
Osteoporos Int. 2011
25-Hydroxyvitamin-D(3) levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study.
Sayers A, Fraser WD, Lawlor DA, Tobias JH. Osteoporos Int. 2011 Nov 12; . Epub 2011 Nov 12.
Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women.
J Clin Lipidol. 2009
Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women.
Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, Lawless A. J Clin Lipidol. 2009 Aug; 3(4):289-96. Epub 2009 Jul 17.
Review Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.
Prog Lipid Res. 2011
Review Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.
Jorde R, Grimnes G. Prog Lipid Res. 2011 Oct; 50(4):303-12. Epub 2011 May 27.
Review Effectiveness and safety of vitamin D in relation to bone health.
Evid Rep Technol Assess (Full ...
Review Effectiveness and safety of vitamin D in relation to bone health.
Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, et al. Evid Rep Technol Assess (Full Rep). 2007 Aug; (158):1-235.